Charles Schwab Investment Management Inc Syndax Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 695,947 shares of SNDX stock, worth $11.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
695,947
Previous 654,489
6.33%
Holding current value
$11.2 Million
Previous $13.4 Million
0.3%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding SNDX
# of Institutions
227Shares Held
88.3MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$127 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$94 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$80.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$78.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$66.1 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $910M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...